RecruitingNCT05842629

Improved Diagnosis of Ovarian Cancer

Sponsor

University of Aarhus

Enrollment

1,700 participants

Start Date

May 15, 2021

Study Type

OBSERVATIONAL

Conditions

Ovarian Cancer Ovarian Neoplasms Adnexal Carcinoma Adnexal Lesion Ovarian Cysts Adnexal Mass Adnexal Neoplasm

Summary

After implementation of systematic image description of adnexal masses, we aim to improve and evaluate our use of available imaging methods and biomarkers for classifying adnexal masses and distinguishing between benign and malignant adnexal masses in the hands of clinicians in Central Denmark Region. Secondarily, we want to improve our management of adnexal masses by evaluating the complications and longitudinal changes in conservatively managed adnexal masses. Data is registered prospectively but analyzed retrospectively.

Eligibility

Sex: FEMALE

Plain Language Summary

Simplified for easier understanding

This study is working to improve how ovarian and pelvic masses are diagnosed. Currently, an ultrasound finding of an adnexal (ovarian or fallopian tube area) mass can be difficult to classify as benign or cancerous. This study collects data to evaluate new imaging and biomarker tools to improve diagnostic accuracy and reduce unnecessary surgery. **You may be eligible if...** - You have been found to have an adnexal (ovarian or pelvic) mass on ultrasound imaging - You are willing to undergo further evaluation as part of the study and can provide informed consent **You may NOT be eligible if...** - You do not have a visible adnexal mass on ultrasound - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Department of Gynaecology and Obstetrics, Aarhus University Hospital

Aarhus, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05842629

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT0731855828 locations

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

NCT06824467164 locations

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

NCT067605071 location

Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology

NCT071674331 location